NOLET MEDCO: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
NOLET MEDCO
Largest movements
- Cash +€39,838
up €39,838 (+1,775%), from €2,245 to €42,083
mainly Net result for the year (+€48,642) and Depreciation (+€3,930)
- Receivables within one year +€5,921
up €5,921 (+41.9%), from €14,126 to €20,047
of which Other amounts receivable: +€7,948
- Tangible fixed assets +€788
up €788 (+6.5%), from €12,158 to €12,945
- Profit (loss) carried forward +€48,642
up €48,642 (+296%), from €16,452 to €65,094
- Tax, wage and social debts -€3,255
down €3,255 (-37.5%), from €8,675 to €5,420
of which Taxes: -€3,745
- Gross operating margin +€61,376
up €61,376 (+1,442%), from €4,255 to €65,631
- Taxes +€12,027
up €12,027 (+1,361%), from €884 to €12,911
- Depreciation +€1,148
up €1,148 (+41.3%), from €2,782 to €3,930
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €29,696 | €75,704 | +€46,008 | +155% |
| Fixed assets | 21/28 | €12,158 | €12,945 | +€788 | +6.5% |
| Tangible fixed assets | 22/27 | €12,158 | €12,945 | +€788 | +6.5% |
| Furniture and vehicles | 24 | €12,158 | €12,945 | +€788 | +6.5% |
| Current assets | 29/58 | €17,538 | €62,759 | +€45,221 | +258% |
| Amounts receivable within one year | 40/41 | €14,126 | €20,047 | +€5,921 | +41.9% |
| Trade receivables | 40 | €4,281 | €2,254 | -€2,027 | -47.4% |
| Other amounts receivable | 41 | €9,845 | €17,793 | +€7,948 | +80.7% |
| Cash at bank and in hand | 54/58 | €2,245 | €42,083 | +€39,838 | +1,775% |
| Deferred charges and accrued income | 490/1 | €1,167 | €629 | -€538 | -46.1% |
| Total equity and liabilities | 10/49 | €29,696 | €75,704 | +€46,008 | +155% |
| Equity | 10/15 | €19,952 | €68,594 | +€48,642 | +244% |
| Contributions | 10/11 | €3,500 | €3,500 | = | 0.0% |
| Profit (loss) carried forward | 14 | €16,452 | €65,094 | +€48,642 | +296% |
| Amounts payable | 17/49 | €9,744 | €7,110 | -€2,634 | -27.0% |
| Amounts payable within one year | 42/48 | €9,474 | €6,320 | -€3,153 | -33.3% |
| Trade debts | 44 | €798 | €900 | +€102 | +12.8% |
| Suppliers | 440/4 | €798 | €900 | +€102 | +12.8% |
| Taxes, remuneration and social security | 45 | €8,675 | €5,420 | -€3,255 | -37.5% |
| Taxes | 450/3 | €6,656 | €2,911 | -€3,745 | -56.3% |
| Remuneration and social security | 454/9 | €2,019 | €2,509 | +€490 | +24.2% |
| Accrued charges and deferred income | 492/3 | €270 | €789 | +€519 | +192% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €2,782 | €3,930 | +€1,148 | +41.3% |
| Other operating charges | 640/8 | €877 | €749 | -€128 | -14.6% |
| Gross operating margin | 9900 | €4,255 | €65,631 | +€61,376 | +1,442% |
| Operating profit (loss) | 9901 | €595 | €60,952 | +€60,356 | +10,140% |
| Financial income | 75/76B | €847 | €758 | -€89 | -10.5% |
| Recurring financial income | 75 | €847 | €758 | -€89 | -10.5% |
| Financial charges | 65/66B | €453 | €156 | -€297 | -65.6% |
| Recurring financial charges | 65 | €453 | €156 | -€297 | -65.6% |
| Profit (loss) for the period before taxes | 9903 | €989 | €61,554 | +€60,565 | +6,125% |
| Income taxes | 67/77 | €884 | €12,911 | +€12,027 | +1,361% |
| Profit (loss) for the period | 9904 | €105 | €48,642 | +€48,537 | +46,226% |
| Profit (loss) for the period to be appropriated | 9905 | €105 | €48,642 | +€48,537 | +46,226% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 24 October 2026 via checked.be.